![Shaheen Tejani](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Shaheen Tejani
Direttore/Membro del Consiglio presso Novation Pharmaceuticals, Inc.
Profilo
Shaheen Tejani is currently a Director at Vancouver General Hospital, Novation Pharmaceuticals, Inc., and University of British Columbia Hospital Foundation.
Previously, she held Principal positions at Vancouver General Hospital, University of British Columbia Hospital Foundation, and Waterstreet Technology Group.
Posizioni attive di Shaheen Tejani
Società | Posizione | Inizio |
---|---|---|
Novation Pharmaceuticals, Inc.
![]() Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Direttore/Membro del Consiglio | - |
Vancouver General Hospital | Direttore/Membro del Consiglio | - |
University of British Columbia Hospital Foundation | Direttore/Membro del Consiglio | - |
Precedenti posizioni note di Shaheen Tejani
Società | Posizione | Fine |
---|---|---|
Vancouver General Hospital | Corporate Officer/Principal | - |
University of British Columbia Hospital Foundation | Corporate Officer/Principal | - |
Waterstreet Technology Group | Corporate Officer/Principal | - |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
Aziende private | 4 |
---|---|
Vancouver General Hospital | |
Novation Pharmaceuticals, Inc.
![]() Novation Pharmaceuticals, Inc. Medical/Nursing ServicesHealth Services Novation Pharmaceuticals, Inc. operates as a biotechnology research and development company. It provides modulation of intracellular messenger RNA (mRNA) to identify new small-molecule therapies to treat serious diseases. The company was founded by Dominique Cheneval and Tania Kastelic and is headquartered in Burnaby, Canada. | Health Services |
University of British Columbia Hospital Foundation | |
Waterstreet Technology Group |
- Borsa valori
- Insiders
- Shaheen Tejani